Literature DB >> 24603796

Harnessing microbiota to kill a pathogen: Fixing the microbiota to treat Clostridium difficile infections.

Ying Taur1, Eric G Pamer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24603796      PMCID： PMC4542075          DOI： 10.1038/nm.3492

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  18 in total

Review 1.  Clostridium difficile--more difficult than ever.

Authors:  Ciarán P Kelly; J Thomas LaMont
Journal:  N Engl J Med       Date:  2008-10-30       Impact factor: 91.245

2.  Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid.

Authors:  Joseph A Sorg; Abraham L Sonenshein
Journal:  J Bacteriol       Date:  2010-07-30       Impact factor: 3.490

3.  Faecal microbiota transplantation and bacteriotherapy for recurrent Clostridium difficile infection: a retrospective evaluation of 31 patients.

Authors:  Frida Emanuelsson; Berndt E B Claesson; Lars Ljungström; Michael Tvede; Kjell-Arne Ung
Journal:  Scand J Infect Dis       Date:  2013-12-20

4.  Suppression of Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family Lachnospiraceae.

Authors:  Angela E Reeves; Mark J Koenigsknecht; Ingrid L Bergin; Vincent B Young
Journal:  Infect Immun       Date:  2012-08-13       Impact factor: 3.441

5.  The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis.

Authors:  Patrick M Smith; Michael R Howitt; Nicolai Panikov; Monia Michaud; Carey Ann Gallini; Mohammad Bohlooly-Y; Jonathan N Glickman; Wendy S Garrett
Journal:  Science       Date:  2013-07-04       Impact factor: 47.728

6.  Duodenal infusion of donor feces for recurrent Clostridium difficile.

Authors:  Els van Nood; Anne Vrieze; Max Nieuwdorp; Susana Fuentes; Erwin G Zoetendal; Willem M de Vos; Caroline E Visser; Ed J Kuijper; Joep F W M Bartelsman; Jan G P Tijssen; Peter Speelman; Marcel G W Dijkgraaf; Josbert J Keller
Journal:  N Engl J Med       Date:  2013-01-16       Impact factor: 91.245

7.  Bile salts and glycine as cogerminants for Clostridium difficile spores.

Authors:  Joseph A Sorg; Abraham L Sonenshein
Journal:  J Bacteriol       Date:  2008-02-01       Impact factor: 3.490

Review 8.  Clostridium difficile infection: new developments in epidemiology and pathogenesis.

Authors:  Maja Rupnik; Mark H Wilcox; Dale N Gerding
Journal:  Nat Rev Microbiol       Date:  2009-07       Impact factor: 60.633

9.  Global analysis of the sporulation pathway of Clostridium difficile.

Authors:  Kelly A Fimlaid; Jeffrey P Bond; Kristin C Schutz; Emily E Putnam; Jacqueline M Leung; Trevor D Lawley; Aimee Shen
Journal:  PLoS Genet       Date:  2013-08-08       Impact factor: 5.917

10.  Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut.

Authors:  Elaine O Petrof; Gregory B Gloor; Stephen J Vanner; Scott J Weese; David Carter; Michelle C Daigneault; Eric M Brown; Kathleen Schroeter; Emma Allen-Vercoe
Journal:  Microbiome       Date:  2013-01-09       Impact factor: 14.650
View more
  16 in total

1.  A small-molecule antivirulence agent for treating Clostridium difficile infection.

Authors:  Kristina Oresic Bender; Megan Garland; Jessica A Ferreyra; Andrew J Hryckowian; Matthew A Child; Aaron W Puri; David E Solow-Cordero; Steven K Higginbottom; Ehud Segal; Niaz Banaei; Aimee Shen; Justin L Sonnenburg; Matthew Bogyo
Journal:  Sci Transl Med       Date:  2015-09-23       Impact factor: 17.956

Review 2.  Infectious diarrhea: an overview.

Authors:  Brandon Dickinson; Christina M Surawicz
Journal:  Curr Gastroenterol Rep       Date:  2014-08

Review 3.  The intestinal microbiome and surgical disease.

Authors:  Monika A Krezalek; Kinga B Skowron; Kristina L Guyton; Baddr Shakhsheer; Sanjiv Hyoju; John C Alverdy
Journal:  Curr Probl Surg       Date:  2016-06-14       Impact factor: 1.909

Review 4.  Therapeutic targeting of bile acids.

Authors:  Michael Camilleri; Gregory J Gores
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-07-02       Impact factor: 4.052

Review 5.  Targeting the gut microbiota for cancer therapy.

Authors:  Miriam R Fernandes; Poonam Aggarwal; Raquel G F Costa; Alicia M Cole; Giorgio Trinchieri
Journal:  Nat Rev Cancer       Date:  2022-10-17       Impact factor: 69.800

6.  Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection.

Authors:  Bruce E Hirsch; Nimit Saraiya; Kaitlin Poeth; Rebecca M Schwartz; Marcia E Epstein; Gerard Honig
Journal:  BMC Infect Dis       Date:  2015-04-17       Impact factor: 3.090

Review 7.  Gut Microbiome and Metabolites in Patients with NAFLD and after Bariatric Surgery: A Comprehensive Review.

Authors:  Jacqueline Hoozemans; Maurits de Brauw; Max Nieuwdorp; Victor Gerdes
Journal:  Metabolites       Date:  2021-05-31

8.  Trophic network architecture of root-associated bacterial communities determines pathogen invasion and plant health.

Authors:  Zhong Wei; Tianjie Yang; Ville-Petri Friman; Yangchun Xu; Qirong Shen; Alexandre Jousset
Journal:  Nat Commun       Date:  2015-09-24       Impact factor: 14.919

Review 9.  Colonization Resistance of the Gut Microbiota against Clostridium difficile.

Authors:  Ana Elena Pérez-Cobas; Andrés Moya; María José Gosalbes; Amparo Latorre
Journal:  Antibiotics (Basel)       Date:  2015-08-07

10.  Diagnosing Clostridium difficile-associated diarrhea using enzyme immunoassay: the clinical significance of toxin negativity in glutamate dehydrogenase-positive patients.

Authors:  Kazuhito Yuhashi; Yuka Yagihara; Yoshiki Misawa; Tomoaki Sato; Ryoichi Saito; Shu Okugawa; Kyoji Moriya
Journal:  Infect Drug Resist       Date:  2016-05-27       Impact factor: 4.003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.